Nicotinamide adenine dinucleotide supplementation drives gut microbiota variation in Alzheimer’s mouse model

Nicotinamide adenine dinucleotide supplementation drives gut microbiota variation in Alzheimer’s mouse model

Alzheimer’s disease (AD) is the most common neurodegenerative disease. Growing evidence suggests an important role for gut dysbiosis and gut microbiota-host interactions in aging and neurodegeneration. Our previous works have demonstrated that supplementation with the nicotinamide adenine dinucleoti...

Descrizione completa

Dettagli Bibliografici
Autori principali: Xixia Chu, Yujun Hou, Qiong Meng, Deborah L. Croteau, Yong Wei, Supriyo De, Kevin G. Becker, Vilhelm A. Bohr
Natura: Articolo
Lingua:English
Pubblicazione: Frontiers Media S.A. 2022-09-01
Serie:Frontiers in Aging Neuroscience
Soggetti:
Alzheimer’s disease
nicotinamide riboside
gut microbiome
APP/PS1 transgenic mice
neuroinflammation
aging
Accesso online:https://www.frontiersin.org/articles/10.3389/fnagi.2022.993615/full

Accesso online

https://www.frontiersin.org/articles/10.3389/fnagi.2022.993615/full

Documenti analoghi